International Business News - ALKS http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Alkermes Inc. said Thursday a long-acting version of its schizophrenia drug Risperdal has been approved for arm injection by U.S. health regulators. The approval by the Food and Drug Administration means Risperdal Consta is cleared for injection in the deltoid muscle of the arm, according to the company. Previously the drug was only approved as a gluteal injection. http://www.ibtimes.com/articles/20081009/fda-approves-new-injection-site-for-risperdal.htm Thu, 09 Oct 2008 16:32:54 EDT Alaska Communications Systems Group Inc. on Monday said its board declared a regular quarterly dividend of 21.5 cents. The broadband company said the dividend is payable Oct. 15 to shareholders of record Sept. 30. http://www.ibtimes.com/articles/20080919/alaska-communications-systems-sets-dividend.htm Fri, 19 Sep 2008 14:33:46 EDT Shares of several diabetes drug developers received a slight boost Tuesday as companies including Eli Lilly & Co. and Merck & Co. touted the effectiveness of their respective treatments in an already highly competitive market. http://www.ibtimes.com/articles/20080909/sector-snap-diabetes-drug-developers.htm Tue, 09 Sep 2008 11:46:42 EDT Amylin Pharmaceuticals Inc. and Eli Lilly & Co. said Tuesday their diabetes drug Byetta worked better at reducing blood-sugar levels following a meal compared with Merck & Co.'s Januvia. http://www.ibtimes.com/articles/20080909/amylin-elli-lilly-tout-diabetes-drug-over-merck.htm Tue, 09 Sep 2008 10:55:39 EDT Shares of Amylin Pharmaceuticals Inc. fell Friday after an analyst suggested Amylin's diabetes drug Byetta is more likely to cause pancreatitis than a rival treatment, Merck & Co.'s Januvia. http://www.ibtimes.com/articles/20080905/amylin-falls-as-analyst-voices-byetta-concerns.htm Fri, 05 Sep 2008 16:58:38 EDT Among the stock activity stories for Wednesday, Aug. 27, from AP Financial News: NEW YORK (AP)--Shares of student lender SLM Corp., better known as Sallie Mae, rose Wednesday after an analyst initiated coverage with an "Accumulate" rating and $23 price target. http://www.ibtimes.com/articles/20080827/movers-roundup-slm-pilgrims-pride.htm Wed, 27 Aug 2008 14:30:04 EDT Shares of Alkermes Inc. declined Wednesday as investors weighed potential bad news for one drug Alkermes helped develop with good news for another. Alkermes helped develop the long-acting formula in Exenatide LAR, a diabetes drug that Eli Lilly and Co. and Amylin Pharmaceuticals are hoping to launch in 2009. It also helped develop the schizophrenia drug Risperdal Consta with Johnson & Johnson. http://www.ibtimes.com/articles/20080827/alkermes-slides-on-diabetes-drug-concerns.htm Wed, 27 Aug 2008 17:24:13 EDT Shares of Amylin Pharmaceuticals Inc. dropped in premarket trading Wednesday after the drug developer and its partner Eli Lilly & Co. reported four new deaths of patients who had taken their diabetes drug Byetta. http://www.ibtimes.com/articles/20080827/ahead-of-the-bell-amylin-drops-on-byetta-deaths.htm Wed, 27 Aug 2008 09:08:22 EDT Eli Lilly and Amylin Pharmaceuticals Inc. on Tuesday reported four new deaths in patients taking Byetta, even as the companies tried to shore up the safety profile of their popular diabetes medication. http://www.ibtimes.com/articles/20080826/companies-report-4-new-deaths-with-diabetes-drug.htm Tue, 26 Aug 2008 22:11:54 EDT Federal regulators warned doctors Tuesday about severe skin reactions seen in patients taking an injectable treatment for alcoholism made by Alkermes Inc. and marketed by Cephalon Inc. http://www.ibtimes.com/articles/20080812/fda-warns-of-skin-reactions-with-alcoholism-drug.htm Tue, 12 Aug 2008 17:29:22 EDT Among the stock activity stories for Friday, Aug. 8, from AP Financial News: NEW YORK (AP)_ Shares of Par Pharmaceutical Cos. plunged Friday after the generic drug developer reported a second-quarter loss and slashed its outlook because of tougher competition and pricing pressure. http://www.ibtimes.com/articles/20080808/movers-roundup-par-pharma-alkermes.htm Fri, 08 Aug 2008 14:50:19 EDT Shares of biotechnology company Alkermes Inc. jumped Friday after the company boosted its fiscal 2009 outlook based on higher-than-expected revenue from the schizophrenia drug Risperdal Consta and lower costs. http://www.ibtimes.com/articles/20080808/alkermes-shares-jump-on-guidance-boost.htm Fri, 08 Aug 2008 10:52:06 EDT Among the earnings stories for Thursday, Aug. 7, from AP Financial News: ATLANTIC CITY, N.J. (AP)--Casino operator Trump Entertainment Resorts Inc. said Thursday its net loss widened in the second quarter, falling short of analysts' estimates, on a decrease in gaming revenue. http://www.ibtimes.com/articles/20080807/earnings-roundup-trump-entertainment-trimeris.htm Thu, 07 Aug 2008 18:09:46 EDT Among the earnings projection stories for Thursday, Aug. 7, from AP Financial News: BURLINGTON, Mass. (AP)--Communications equipment maker Acme Packet Inc. sharply lowered its 2008 profit and sales outlook Thursday. http://www.ibtimes.com/articles/20080807/outlook-roundup-acme-packet-i2-technologies.htm Thu, 07 Aug 2008 17:51:47 EDT Biotechnology company Alkermes Inc. raised its full-year profit outlook, citing higher revenue from the schizophrenia drug Risperdal Consta and lower costs. http://www.ibtimes.com/articles/20080807/alkermes-raises-full-year-profit-revenue-outlook.htm Thu, 07 Aug 2008 16:39:55 EDT Biotechnology company Alkermes Inc. said Thursday its fiscal 2009 first-quarter profit surged more than threefold on a payment from former partner Eli Lilly & Co. http://www.ibtimes.com/articles/20080807/alkermes-fiscal-1q-profit-jumps-on-payment.htm Thu, 07 Aug 2008 16:32:12 EDT Proposals for tougher heart-risk studies on new Type 2 diabetes drugs weighed heavy on shares of Amylin Pharmaceuticals Inc. and Novo Nordisk AS Thursday, since stricter regulations could mean longer, more costly clinical trials. http://www.ibtimes.com/articles/20080703/sector-snap-diabetes-drug-developers.htm Thu, 03 Jul 2008 11:34:53 EDT Shares of Novo Nordisk AS rose more than 3 percent Tuesday after a Goldman Sachs analyst upgraded the stock to "Buy" from "Neutral," saying the Danish drug maker is well-positioned for continued strong growth. http://www.ibtimes.com/articles/20080624/goldman-sachs-upgrades-novo-nordisk-to-buy.htm Tue, 24 Jun 2008 13:30:07 EDT Large-cap biotech stocks are better positioned to bring investors returns during the second half of 2008 due to revenue gains and development deals, J.P. Morgan analysts said Tuesday. http://www.ibtimes.com/articles/20080624/sector-snap-biotech-_-large-cap-or-small-cap.htm Tue, 24 Jun 2008 12:51:24 EDT Among the earnings projection stories for Monday, June 16, from AP Financial News: HARTFORD, Conn. (AP)--Shares of General Electric Co. briefly fell to their lowest point in more than four years Monday when an analyst downgraded the company's shares and predicted a challenging environment for its business operations. http://www.ibtimes.com/articles/20080616/outlook-roundup-general-electric-atlas-pipeline.htm Mon, 16 Jun 2008 14:44:18 EDT